<b>Gapping up <br/>In reaction to strong earnings/guidance: </b>LNN +8.2%, ULTA +4.2%, NEPT +3.4%, SAR +3.3%, TSM +1.7%, CSX +0.8%<br/><br/><b>Select metals/mining stocks trading higher:</b> SBGL +3.6%, GFI +2%, HMY +1.7%, AG +1%, GG +1%, ABX +0.6%, GOLD +0.6%, GDX +0.6%, SLW +0.6%<br/><br/><b>Other news:</b> CTRV +29.5% (reports interim data for CMX157 from its ongoing Phase 2a multiple ascending dose clinical studyg), OCUL +27.6% (Ocular Therapeutix & Regeneron (REGN) enter into a collaboration to develop sustained release formulation of Aflibercept for the treatment of Wet AMD and other serious retinal diseases), CI +2.5% (CIGNA responds to CMS's 2017 Medicare Stars Quality Ratings; no financial impact in 2016 or 2017 because these ratings apply to plans for the 2018 payment year), FCN +2.4% (its Strategic Communications segment has launched a new and enhanced Affiliate Network), ERJ +2.2% (upgraded to Buy from Neutral at Goldman), STM +1.9% (in sympathy with TSM (earnings)), EBAY +1.2% (MercadoLibre commences a 5.5 mln share underwritten public offering of common stock by selling stockholders eBay & certain subsidiaries; eBay says sale will enable it to realize a significant gain on its investment), AAMC +1% (after 30%+ move higher), WFC +0.9% (Wells Fargo Chairman, CEO John Stumpf retires; Board of Directors elects Tim Sloan CEO, Director; appoints Lead Director Stephen Sanger Chairman)<br/><br/><b>Analyst comments</b>: ERJ +2.2% (upgraded to Buy from Neutral at Goldman), VIAB +1.5% (upgraded to Buy from Underperform at BofA/Merrill), GRUB +1.1% (upgraded to Buy from Neutral at BofA/Merril), MRK +0.8% (upgraded to Buy from Neutral at BofA/Merrill), ALK +0.8% (upgraded to Buy from Neutral at Buckingham Research)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b> FLDM -20.6%, (issues Q3 prelim revenue numbers of ~$22.2 mln vs. $29.3 mln Capital IQ Consensus Est; as a result of its Q3 prelim numbers, co is suspending its full year 2016 guidance), VAC -6.4%, INSY -5.2%, UN -2.7%, DRWI -2.6%, MYCC -1.2%, APU -1%, DAL -0.9%, WGO -0.7%<br/><br/><b>Select financial related names showing weakness</b>: SAN -3.4%, RBS -3.2%, DB -2.8%, BBVA -2.2%, CS -2.1%, HSBC -1.8%<br/><br/><b>Select metals/mining stocks trading lower:</b> BBL -4.4%, RIO -4.4%, FCX -4%, BHP -4%, X -3.9%, VALE -3.6%<br/><br/><b>Other news: </b>APTO -18.4% (receives a response from the FDA regarding the clinical hold of its Phase 1b clinical trial of APTO-253; the hold would not be removed at this time), FLKS -17% (provides a nocturnal leg cramp regulatory and clinical update for FLX-787; Exploratory NLC study 'did not demonstrate a statistically significant difference versus placebo), TGTX -15.2% (files with FDA an amended protocol for the GENUINE Phase 3 trial, FDA agrees that Overall Response Rate data from revised GENUINE study can be used to request pre-BLA meeting ), MELI -6.1% (MercadoLibre commences a 5.5 mln share underwritten public offering of common stock by selling stockholders eBay & certain subsidiaries; MercadoLibre offers prelim Q3 results in conjunction with today's proposed secondary offering, sees revs of $220-290 mln vs $222.13 mln Capital IQ Consensus Estimate ), VOXX -5.3% (light volume in after hours -- was up nearly 50% today on earnings), HTGM -3.2% (after jumping 35% on broad companion diagnostics master agreement w/ Merck KGaA news), BABA -1.6% (Chairman Jack Ma letter to shareholders)<br/><b><br/>Analyst comments:</b> MT -2.4% (downgraded to Neutral from Buy at Goldman), BEAV -2.9% (downgraded to Neutral from Buy at Goldman), HDP -3.5% (downgraded to Sell from Buy at Goldman), GPRO -3.8% (Piper Jaffray noted co is not selling on Amazon (12-14% of sales) right now but should be back on that channel around Halloween), DECK -5.1% (downgraded to Neutral from Positive at Susquehanna)<br/><br/>Briefing.com